Signos Glucose Monitoring System
AI-powered CGM platform for weight management and metabolic health
Company profile
Company profile
Signos is a real-time metabolic health platform that combines an AI-powered app with a continuous glucose monitor to help with weight management.
Company description Signos official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Embedded deployment with recorded integration context.
Recorded integration context: Apple Health, Dexcom Stelo CGM, Google Health Connect, smart scales, smartwatches.
Company milestones
First and only FDA-cleared AI-driven app and CGM for weight management and wellness. Partnership with Berry Street for dietitian services where 95% of members pay $0.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered CGM platform for weight management and metabolic health
15-day continuous glucose biosensor integrated with Signos platform
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Diabetes technology & therapeutics · Jun 12, 2026
Exploratory identification of intestinal health and productive performance patterns in post-weaning piglets using explainable machine learning.Veterinary research communications · Feb 4, 2026
Novel Glucose Metric "Latest Spike Time" Correlated with Weight Loss at Six Months in People with Obesity Using the Signos System.Diabetes technology & therapeutics · Jan 1, 2025
Environment diagnosis for land-use planning based on a tectonic and multidimensional methodology.The Science of the total environment · Dec 15, 2021
Fourier analysis of videokeratography data: Clinical usefulness in grade I and subclinical keratoconus.Journal of cataract and refractive surgery · May 1, 2016
In vitro antiviral activity against rotavirus and astrovirus infection exerted by substances obtained from Achyrocline bogotensis (Kunth) DC. (Compositae).BMC complementary and alternative medicine · Dec 3, 2015
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Weight management and metabolic health outcomes
Based on glucose feedback
Behavioral change from real-time feedback
User-reported lifestyle improvement
Learning to hack metabolism and understand body better for weight management
Getting a ton of compliments with very obvious impact
Weight loss after trying diets and exercise without success
Successfully lost weight - described as the only thing that helped after trying everything
Weight loss during hormonal changes when old strategies stopped working
Steady weight loss achieved by adjusting habits with confidence using real glucose data
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Signos's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to optimize metabolic health, provide personalized nutrition recommendations, or analyze metabolic responses to food for generally healthy or non-diabetic populations. Emphasizes wellness, performance optimization, and preventive health rather than management of a diagnosed disease.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.